CLINICAL_TRIALS
trial_result
· 2012-02-27
Clinical Trial Update: Effect on Primary Dysmenorrhea [Phase 3]
Summary
A Phase 3 trial sponsored by Bayer assessing treatment for primary dysmenorrhea has completed and posted results (as of February 27, 2012).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Bayer | Conditions: Primary Dysmenorrhea | Phase 3 | Status: COMPLETED | Results posted: 2012-02-27